Clin2
NCT07554885Worth exploringNot yet recruiting

Nutritional supplement and steroids for lung inflammation from cancer treatment

Immune Checkpoint Inhibitor-Related PneumonitisDrug-Related Side Effects and Adverse ReactionsNeoplasms

Treatments studied

Part of Cancer, Infections, Lungs & breathing clinical trials.

This study tests whether adding a special nutritional supplement to the usual steroid treatment helps people recover from lung inflammation caused by cancer immunotherapy. If you have grade 3-4 immune-related pneumonitis, this trial may offer a way to improve your recovery.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
60 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You are 18 to 75 years old.
  • You have been diagnosed with cancer that is confirmed by biopsy.
  • You have already received at least one round of immunotherapy (immune checkpoint inhibitors).
  • You have moderate to severe lung inflammation (pneumonitis) caused by the immunotherapy.
  • You are able to take care of yourself (ECOG performance status 0-2) and are expected to live more than 3 months.
  • Your organs are working well enough, based on blood tests, and you are not taking certain antibiotics or probiotics within 2 weeks before starting.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07340892Recruiting
Finding markers to predict lung inflammation from immunotherapy

This study looks for signs in the blood that can tell if a lung cancer patient is developing a side effect called pneumonitis (lung inflammation) from checkpoint inhibitor treatment. It may help doctors catch and treat this side effect early.

Guangzhou, Guangdong
NCT07874464Not yet recruiting· Phase 2
Radiation plus two immunotherapy medicines for stage 3 lung cancer

This trial looks at adding two immunotherapy drugs to radiation and chemotherapy for people with stage 3 lung cancer that cannot be removed by surgery. It compares giving immunotherapy during radiation versus giving it after radiation, to see which way may help control the cancer better.

Guangzhou, Guangdong
NCT06428422Recruiting
Probiotic supplement for advanced lung cancer

This trial tests if taking a probiotic supplement along with your standard lung cancer treatment can help you live longer and respond better to therapy. It is for people with advanced non-small cell lung cancer who have not tried immunotherapy before.

Konya
NCT06860542Recruiting· Phase 2
Inhaled steroid to prevent lung inflammation from returning after immunotherapy

This trial tests whether using an inhaled steroid (budesonide) can help prevent lung inflammation (pneumonitis) from coming back in people who have had it caused by immunotherapy cancer treatment. It may be an option for patients who need extra support after their first bout of this side effect.

Calgary, Alberta
NCT07241182Recruiting
Mushroom extract supplement for lung cancer chemo patients

This study tests whether a supplement from a medicinal mushroom (Antrodia cinnamomea, also known as niu zhang zhi) can improve quality of life for people with lung cancer who are receiving platinum-based chemotherapy.

Taipei
NCT05384873Recruiting
Immunonutrition to improve immunotherapy in metastatic lung cancer

This trial studies whether adding special nutrition (oral immunonutrition supplements) can help immunotherapy work better in people with metastatic non-small cell lung cancer. Participants receive immunotherapy, with or without chemotherapy, and must be able to take oral supplements.

Pavia

Hear when a new Drug-Related Side Effects and Adverse Reactions trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.